Entrada Therapeutics, Inc. logo

Entrada Therapeutics, Inc.

NASDAQ:TRDA

Overview | Financials
Company Name Entrada Therapeutics, Inc.
Symbol TRDA
Currency USD
Price 15
Market Cap 557,993,250
Dividend Yield 0%
52-week-range 10.75 - 18.17
Industry Biotechnology
Sector Healthcare
CEO Mr. Dipal Doshi
Website https://www.entradatx.com

An error occurred while fetching data.

About Entrada Therapeutics, Inc.

Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in preclinical trail for the treatment of Duchenne

Related Stocks

Accuray Incorporated logo

Accuray Incorporated

ARAY

2.19 USD

Semler Scientific, Inc. logo

Semler Scientific, Inc.

SMLR

25.92 USD

G1 Therapeutics, Inc. logo

G1 Therapeutics, Inc.

GTHX

7.15 USD

Hyperfine, Inc. logo

Hyperfine, Inc.

HYPR

1.04 USD

XOMA Corporation logo

XOMA Corporation

XOMA

28.98 USD

Altimmune, Inc. logo

Altimmune, Inc.

ALT

7.88 USD

Kamada Ltd. logo

Kamada Ltd.

KMDA

4.23 USD

Nuvectis Pharma, Inc. logo

Nuvectis Pharma, Inc.

NVCT

6.67 USD

Financials

Numbers are in millions USD

Numbers are in millions USD